Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mate Vamos

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Deutsche Medizinische Wochenschrift (1946)|August 30, 2017
Andras Simon, Mate Vamos
Circulation. Arrhythmia and Electrophysiology|January 13, 2017
Not All Types of Atrial Fibrillation Carry the Same Stroke Risk, but Most Benefit From Oral AnticoagulationStefan H Hohnloser, Mate Vamos
Trends in Cardiovascular Medicine|May 9, 2016
Amiodarone and dronedarone: An updateMate Vamos, Stefan H Hohnloser
Herzschrittmachertherapie & Elektrophysiologie|January 6, 2022
Implantation of a VDD implantable cardioverter-defibrillator lead via a persistent left superior vena cavaMate Vamos, Laszlo Saghy, Gabor Bencsik
Herzschrittmachertherapie & Elektrophysiologie|November 2, 2023
Use of mexiletine in therapy-refractory recurrent ventricular tachycardia stormMihaly D Szonyi, Robert Pap, Mate Vamos
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Effects of digitalis on mortality in a large cohort of implantable cardioverter defibrillator recipients: results of a long-term follow-up study in 1020 patientsJulia W Erath, Mate Vamos, Stefan H Hohnloser
Expert Opinion on Pharmacotherapy|June 12, 2023
Indications for mexiletine in the new ESC guidelines and beyondMate Vamos, Elod-Janos Zsigmond, Stefan H Hohnloser
European Heart Journal|May 6, 2015
Digoxin-associated mortality: a systematic review and meta-analysis of the literatureMate Vamos, Julia W Erath, Stefan H Hohnloser
Arrhythmia & Electrophysiology Review|February 3, 2016
Optimal Anticoagulation Strategy for Cardioversion in Atrial FibrillationPhilipp Bushoven, Sven Linzbach, Mate Vamos, et al.
Journal of Cardiovascular Development and Disease|October 27, 2023
Useful Electrocardiographic Signs to Support the Prediction of Favorable Response to Cardiac Resynchronization TherapyAndras Simon, David Pilecky, Loretta Zsuzsa Kiss, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Deutsche Medizinische Wochenschrift (1946)|August 30, 2017
Andras Simon, Mate Vamos
Circulation. Arrhythmia and Electrophysiology|January 13, 2017
Not All Types of Atrial Fibrillation Carry the Same Stroke Risk, but Most Benefit From Oral AnticoagulationStefan H Hohnloser, Mate Vamos
Trends in Cardiovascular Medicine|May 9, 2016
Amiodarone and dronedarone: An updateMate Vamos, Stefan H Hohnloser
Herzschrittmachertherapie & Elektrophysiologie|January 6, 2022
Implantation of a VDD implantable cardioverter-defibrillator lead via a persistent left superior vena cavaMate Vamos, Laszlo Saghy, Gabor Bencsik
Herzschrittmachertherapie & Elektrophysiologie|November 2, 2023
Use of mexiletine in therapy-refractory recurrent ventricular tachycardia stormMihaly D Szonyi, Robert Pap, Mate Vamos
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Effects of digitalis on mortality in a large cohort of implantable cardioverter defibrillator recipients: results of a long-term follow-up study in 1020 patientsJulia W Erath, Mate Vamos, Stefan H Hohnloser
Expert Opinion on Pharmacotherapy|June 12, 2023
Indications for mexiletine in the new ESC guidelines and beyondMate Vamos, Elod-Janos Zsigmond, Stefan H Hohnloser
European Heart Journal|May 6, 2015
Digoxin-associated mortality: a systematic review and meta-analysis of the literatureMate Vamos, Julia W Erath, Stefan H Hohnloser
Arrhythmia & Electrophysiology Review|February 3, 2016
Optimal Anticoagulation Strategy for Cardioversion in Atrial FibrillationPhilipp Bushoven, Sven Linzbach, Mate Vamos, et al.
Journal of Cardiovascular Development and Disease|October 27, 2023
Useful Electrocardiographic Signs to Support the Prediction of Favorable Response to Cardiac Resynchronization TherapyAndras Simon, David Pilecky, Loretta Zsuzsa Kiss, et al.
Pageof 7